What is Tirzepatide, and how does it work?
Tirzepatide is a novel, investigational, once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity. It represents a significant advancement in the field of metabolic medicine due to its dual action on GIP and GLP-1 receptors, which play crucial roles in glucose and weight regulation.
Tirzepatide works by activating both the GIP and GLP-1 receptors, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and reduced appetite. This dual action contributes to improved glycemic control and expedite weight loss.














Victoria Freeman (verified owner) –
I absolutely love your product, and I’m excited to keep ordering from you. I’m looking forward to an amazing experience together